Paper36944688
TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation.
Zeng F and 4 others. Sci Rep, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation. Papers, record 36944688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944688
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| TNF Receptor-Associated Factor 6 | Major topic |
| Animals | |
| Female | |
| Humans | |
| Mice | |
| TNF Receptor-Associated Factor 2 | |
| Ubiquitin-Protein Ligases | |
| Intracellular Signaling Peptides and Proteins |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27151821 | Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway. | Sci Rep | 2016 | https://conductscience.org/library/papers/27151821 | PubMed |
| 2 | 34453532 | The immunological significance of tumor necrosis factor receptor-associated factors (TRAFs). | Int Immunol | 2022 | https://conductscience.org/library/papers/34453532 | PubMed |
| 3 | 26747895 | miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer. | Cancer Res | 2016 | https://conductscience.org/library/papers/26747895 | PubMed |
| 4 | 36011046 | TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36011046 | PubMed |
| 5 | 25249198 | TRAF4 mediates activation of TGF-β signaling and is a biomarker for oncogenesis in breast cancer. | Sci China Life Sci | 2014 | https://conductscience.org/library/papers/25249198 | PubMed |
| 6 | 30476243 | STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30476243 | PubMed |
| 7 | 29684350 | Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29684350 | PubMed |
| 8 | 24667063 | SYRCLE's risk of bias tool for animal studies. | BMC Med Res Methodol | 2014 | https://conductscience.org/library/papers/24667063 | PubMed |
| 9 | 23758787 | TRAF molecules in cell signaling and in human diseases. | J Mol Signal | 2013 | https://conductscience.org/library/papers/23758787 | PubMed |
| 10 | 33338382 | BatchServer: A Web Server for Batch Effect Evaluation, Visualization, and Correction. | J Proteome Res | 2021 | https://conductscience.org/library/papers/33338382 | PubMed |
| 11 | 19622511 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19622511 | PubMed |
| 12 | 30627694 | Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review. | JNCI Cancer Spectr | 2018 | https://conductscience.org/library/papers/30627694 | PubMed |
| 13 | 34036857 | Dysregulation of tumour microenvironment driven by circ-TPGS2/miR-7/TRAF6/NF-κB axis facilitates breast cancer cell motility. | Autoimmunity | 2021 | https://conductscience.org/library/papers/34036857 | PubMed |
| 14 | 7592751 | Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7592751 | PubMed |
| 15 | 9744859 | Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. | Genes Dev | 1998 | https://conductscience.org/library/papers/9744859 | PubMed |
| 16 | 26095299 | CXCR4 3'UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity. | Eur J Cell Biol | 2015 | https://conductscience.org/library/papers/26095299 | PubMed |
| 17 | 33229340 | Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion. | Cancer Res | 2021 | https://conductscience.org/library/papers/33229340 | PubMed |
| 18 | 29311633 | TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. | Sci Rep | 2018 | https://conductscience.org/library/papers/29311633 | PubMed |
| 19 | 27161491 | The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. | Nat Commun | 2016 | https://conductscience.org/library/papers/27161491 | PubMed |
| 20 | 29324741 | Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies. | PLoS One | 2018 | https://conductscience.org/library/papers/29324741 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42292474 | Host factors in parainfluenza virus replication: from entry to innate immunity evasion. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292474 | PubMed |
| 42196397 | Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196397 | PubMed |
| 42121919 | The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies. | Cells | 2026 | https://conductscience.org/library/papers/42121919 | PubMed |
| 40878344 | Prognostic significance of the kinesin superfamily in breast cancer: A systematic review & meta-analysis. | Indian J Med Res | 2025 | https://conductscience.org/library/papers/40878344 | PubMed |
| 40448788 | Application of Systematic Review and Meta-Analysis in Musculoskeletal Research. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40448788 | PubMed |
| 40305047 | Nonproteolytic ubiquitination regulates chromatin occupancy by the NCoR/SMRT/HDAC3 corepressor complex in MCF-7 breast cancer cells. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40305047 | PubMed |
| 39061144 | ENO2, a Glycolytic Enzyme, Contributes to Prostate Cancer Metastasis: A Systematic Review of Literature. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39061144 | PubMed |
| 37626927 | Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies. | Cells | 2023 | https://conductscience.org/library/papers/37626927 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944688
GET https://conductscience.org/api/papers/v1/36944688/references?page=2